Meeting
2016 Genitourinary Cancers Symposium
The change in prostate cancer presentation and diagnosis coinciding with screening recommendations.
Authors
Franklin Gaylis
Genesis Healthcare Partners, San Diego, CA
Franklin Gaylis , Jae Choi , Paul Dato , Edward Cohen , Renee Calabrese , Hillary Prime , A. Karim Kader
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 95)
DOI
10.1200/jco.2016.34.2_suppl.95
Abstract #
95
Poster Bd #
E11
Abstract Disclosures
Similar Posters
Poster
2016 Genitourinary Cancers Symposium
The risk-based STHLM3 model to improve prostate cancer testing in men 50-69 years: Further health, economic, and clinic evaluation.
First Author: Henrik Gronberg
Poster
2022 ASCO Annual Meeting
Methylated DNA markers in urine aid in the selective identification of patients with prostate cancer as well as clinically significant pathology.
First Author: Paras Shah
Poster
2022 ASCO Genitourinary Cancers Symposium
Impact of COVID-19 on the incidence of prostate cancer among White and Black Veterans.
First Author: Kyung Min Lee
Poster
2018 Genitourinary Cancers Symposium
Evaluation of the MiCheck MIA test performance in differentiating aggressive from non-aggressive prostate cancer: The MiCheck-01 prospective trial.
First Author: Neal D. Shore